HALO logo
halo search icon
VRTX
Vertex Pharmaceuticals Incorporated

VRTX · Vertex Pharmaceuticals Incorporated

477.36

USD
4.27 (0.903%)
24/07/2026 04:00:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$120.07B

PE

0.00

EV/EBITDA

21.4

DIV Yield

0%

Payout Ratio

0%

MQV Rating

3Neutral

As at 24/07/2026 04:00:00 PM

Price Chart

Description

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Balance Sheet
  • Hammer Bullish
  • Hammer Bullish (Realtime)

Key Fundamentals

EPS 3 yr Growth

-122.90%

EBITDA Margin

41.60%

Operating Cashflow

-$493m

Free Cash Flow Return

-2.70%

ROIC

-2.90%

Interest Coverage

149.20

Quick Ratio

2.40

Performance

52 weeks range

Low 362.5 - 533.67

Trade Value (12mth)

US$169,446,544.00

1 week

-2.66%

1 month

-0.44%

YTD

4.64%

1 year

0.17%

All time high

533.67

Additional Data

Shares Outstanding (Fully Diluted)

260m

HALO Sector

Healthcare

Next Company Report Date

09-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Neutral

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
07 July 26EDG
07 July 26EDG
14 May 26EDG
14 May 26EDG
14 May 26EDG

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The current share price of Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$477.36.
2
What is the 52-week high share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The 52-week high share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$533.67.
3
What is the 52-week low share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The 52-week low share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$362.50.
4
What is the dividend yield for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) does not pay a dividend.
5
What was Vertex Pharmaceuticals Incorporated (VRTX:NAS) last dividend payment?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) does not pay a dividend.
6
What is the franking level for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) has a franking level of 0.00%.
7
In which sector is Vertex Pharmaceuticals Incorporated (VRTX:NAS) classified?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) is classified in the Healthcare.